Advertisement

Pharmacy World and Science

, Volume 27, Issue 3, pp 258–262 | Cite as

Use of Antiplatelet Drugs in the Stroke Unit of a Hong Kong Hospital

  • Ho Hoi Luk
  • Janet PangEmail author
  • Leonard Sheung Wai Li
  • Matthew Ng
Article

Abstract

Objective: Antiplatelet drugs are widely used for secondary prevention of thrombotic cerebrovascular disease. The antiplatelet prescribing patterns has been evaluated in several studies but data about Hong Kong patients are lacking. This study is to investigate the prescribing patterns of antiplatelet agents in a Hong Kong hospital.

Method: All patients over 18 years, who attended the stroke unit between 1 October 2002 and 31 December 2002 and were on antiplatelet therapy were included in the study. Data were collected through retrospective chart review and recorded on a standardized data collection form. Continuous and categorical data were expressed as mean and counts respectively. Factors that determine frequency and pattern of antiplatelet therapy were assessed in multiple logistic regression models.

Results: Three hundred and nineteen patients were included in the study. Aspirin and clopidogrel accounted for 82.1 and 16.3 of all prescriptions respectively and remaining patients were on aspirin/dipyridamole. Patients with no history of aspirin use were less likely to be treated with clopidogrel compared with those experienced aspirin intolerance (OR=0.004, 95 CI 0.000–0.051). Patients with history of gastrointestinal (GI) diseases were more likely to receive clopidogrel than those had no history of GI disorders (OR=154.86, 95 CI 33.76–710.38). Atrial fibrillation (AF) was positively associated with clopidogrel prescription (OR=11.83, 95 CI 1.21–115.85). In addition, patients with concomitant gastroprotective drugs received clopidogrel significantly less often than those without gastroprotective agents (OR=0.06, 95 CI 0.01–0.29).

Conclusion: Use of antiplatelet agents in patients receiving antiplatelet therapy of the stroke unit has complied with existing evidences. Several factors that determine choice between aspirin and clopidogrel were identified which included history of aspirin use and GI disorders, AF and co-prescribed gastroprotective drugs.

Keywords

Acetylsalicylic acid Antiplatelet drugs Aspirin Clopidogrel Dipyridamole Hong Kong Prescribing pattern 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Antithrombotic Trialists’ Collaboration.2002Collaborative meta-analysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patientsBMJ3247186Google Scholar
  2. Albers, GW, Tijssen, JGP. 1999Antiplatelet therapy: new foundations for optimal treatment decisionsNeurology53S25S31PubMedGoogle Scholar
  3. Schror, K. 1995Antiplatelet drugsDrugs50728PubMedGoogle Scholar
  4. CAPRIE Steering Committee.1996A randomised, blinded trial of clopidogrel versus aspirin in patients at risk of ischaemic events (CAPRIE)Lancet348132938Google Scholar
  5. Gorelick, PB, Born, GVR, D’Agostino, RB, Hanley, DF, Moye, L, Pepine, CJ. 1999Therapeutic benefit: aspirin revisited in light of the introduction of clopidogrelStroke30171621PubMedGoogle Scholar
  6. Lalouschek, W, Lang, W, Mullner, M. 2001Current strategies of secondary prevention after a cerebrovascular event: The Vienna Stroke RegistryStroke3228606PubMedGoogle Scholar
  7. Mayer, TO, Biller, J. 2003Antiplatelet prescribing patterns for TIA and ischemic stroke: the Indiana University experienceJ Neurol Sci879416Google Scholar
  8. Diener, HC, Cunha, L, Forbes, C, Sivenius, J, Smets, P, Lowenthal, A. 1996European stroke prevention study 2: dipyridamole and acetylsalicylic acid in the secondary prevention of strokeJ Neurol Sci143113PubMedGoogle Scholar
  9. Jaglal, SB, Goel, V, Naylor, CO. 1994Sex differences in the use of invasive coronary procedures in OntarioCan J Cardiol1023944PubMedGoogle Scholar
  10. Holroyd-Leduc JM, Kapral MK, Austin PC, Tu JV. (2000). Sex differences and similarities in the management and outcome of stroke patient. Stroke 1833–37Google Scholar
  11. Gaspoz, JM, Coxson, PG, Goldman, PA, Williams, LW, Kuntz, KM, Hunink, M, Goldman, L. 2002Cost effectiveness of aspirin, clopidogrel, or both for secondary prevention of coronary heart diseaseN Engl J Med346180006CrossRefPubMedGoogle Scholar
  12. Wolfe, MM, Lichtenstein, DR, Singh, G. 1999Gastrointestinal toxicity of nonsteroidal antiinflammatory drugsN Engl J Med340188899CrossRefPubMedGoogle Scholar
  13. Vane, JR, Botting, RM. 1998Mechanism of Action of Nonsteroidal Anti-inflammatory DrugsAm J Med1042S8SCrossRefGoogle Scholar
  14. Chan, FKL, Leung, WK. 2002Peptic-ulcer diseaseLancet36093340CrossRefPubMedGoogle Scholar
  15. Seey, , Ng, SC, Tho, KS, Teo, SK. 1998Are antacids necessary as routine prescriptives with non-steroidal anti-inflammatory drugsAnn Acad Med Singap2721922PubMedGoogle Scholar
  16. LazzaroniM. Sainaghi, M, Bianchi, PG. 1999Non-steroidal anti-inflammatory drug gastropathy: clinical results with antacids and sucralfateItal J Gastroenterol Hepatol31S48S53PubMedGoogle Scholar
  17. Singh, G, Triadafilopoulos, G. 1999Epidemiology of NASID induced gastrointestinal complicationsJ Rheumatology261824Google Scholar
  18. Singh, G. 1998Recent considerations in nonsteroidal anti-inflammatory drug gastropathyAm J Med10531S38SCrossRefPubMedGoogle Scholar
  19. International Stroke Trial Collaborative Group.1997The international stroke trial (IST): a randomised trial of aspirin, subcutaneous heparin, both, or neither among 19435 patients with acute ischemic strokeLancet349156981Google Scholar
  20. CAST (Chinese Acute Stroke Trial) Collaborative Group.1997CAST: randomised placebo-controlled trial of early aspirin use in 20,000 patients with acute ischemic strokeLancet349164149Google Scholar
  21. Vaughan, CJ, Delanty, N, Basson, CT. 2001Statin therapy and stroke preventionCurr Opin Cardiol1621924CrossRefPubMedGoogle Scholar
  22. Gorelick, PB. 2002Stroke prevention therapy beyond antithrombotics: unifying mechanisms in ischemic stroke pathogenesis and implications for therapyStroke3386275CrossRefPubMedGoogle Scholar

Copyright information

© Springer 2005

Authors and Affiliations

  • Ho Hoi Luk
    • 1
  • Janet Pang
    • 1
    Email author
  • Leonard Sheung Wai Li
    • 2
  • Matthew Ng
    • 2
  1. 1.Department of PharmacyTung Wah HospitalSheung WanChina
  2. 2.Department of MedicineTung Wah HospitalChina

Personalised recommendations